Diagnosis of clear cell sarcoma by real-time reverse transcriptase-polymerase chain reaction analysis of paraffin embedded tissues - Clinicopathologic and molecular analysis of 44 patients from the French sarcoma group

被引:59
作者
Coindre, Jean-Michel
Hostein, Isabelle
Terrier, Philippe
Bouvier-Labit, Corinne
Collin, Francoise
Michels, Jean-Jacques
Trassard, Martine
Marques, Bernard
Ranchere, Dorninique
Guillou, Louis
机构
[1] Inst Bergonie, Dept Pathol, F-33076 Bordeaux, France
[2] Univ Victor Segalen, Lab Pathol, Bordeaux, France
[3] Inst Gustave Roussy, Dept Pathol, Villejuif, France
[4] Hop La Timone, Dept Pathol, Marseille, France
[5] Ctr Georges Francois Leclerc, Dept Pathol, Dijon, France
[6] Ctr Francois Baclesse, Dept Pathol, Caen, France
[7] Ctr Rene Huguenin, Dept Pathol, St Cloud, France
[8] Inst Claudius Regaud, Dept Pathol, Toulouse, France
[9] Ctr Leon Berard, Dept Pathol, Lyon, France
[10] Univ Lausanne, Inst Pathol, Lausanne, Switzerland
关键词
clear cell sarcoma; ATF1; real-time polymerase chain reaction; paraffin embedded tissues; prognosis;
D O I
10.1002/cncr.22099
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Clear cell sarcoma (CCS) is a rare tumor with a very poor prognosis that occurs predominantly in the distal extremities of young adults. Most patients bear the t(12;22) reciprocal translocation, which involves the EWS and ATF1 genes. The diagnosis of CCS usually is easy but may be challenging in unusual sites, and the detection of EWS-ATF1 fusion transcripts is helpful to rule out a metastatic melanoma. METHODS. Forty-four patients with CCS and 14 conventional melanomas were examined for the presence of EITS-ATF1 transcripts by using real-time polymerase chain reaction (PCR) analysis on paraffin embedded tissues, including frozen samples for 9 CCS samples and 9 melanoma samples. Prior to molecular analysis, the diagnosis of CCS was considered certain in 35 patients and as probable in 9 patients on the basis of location, histologic features, and immunohistochemical profile. Treatment modalities and follow-up were available for 41 patients with CCS. RESULTS. EWS-ATF1 fusion transcripts were detected in 38 paraffin embedded CCS tissues (86% of all samples; 93% of interpretable samples), 3 samples (7%) were negative, and 3 samples (7%) were considered on interpretable. Fusion transcripts were detected in 7 of 9 samples for which the diagnosis of CCS was considered probable. EWS-ATF1 transcripts were not detected in the 14 samples of melanoma. Results from frozen tissues were concordant with those from all corresponding paraffin embedded samples. Twenty-eight of 41 patients (68%) experienced lymph node and/or distant metastasis, and the 5 year-survival rate was 44%. Mitotic index and histologic grade were predictive of survival and distant metastasis. CONCLUSIONS. The results of this study showed that the molecular detection of EWS-ATF1 fusion transcript by real-time PCR on paraffin embedded tissues is a sensitive and specific method for the diagnosis of CCS. It is an efficient tool for the diagnosis of unusual tumors, especially with regard to its distinction from melanoma. The current results also confirmed the poor prognosis for patients with this tumor type. Mitotic index and grade were predictive factors for survival and distant metastasis.
引用
收藏
页码:1055 / 1064
页数:10
相关论文
共 28 条
[1]  
[Anonymous], 2002, MEDICINE
[2]  
[Anonymous], 1993, INT J SURG PATHOL, DOI 10.1177/106689699300100201
[3]  
Antonescu CR, 2006, LAB INVEST, V86, p8A
[4]   Molecular diagnosis of clear cell sarcoma -: Detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases [J].
Antonescu, CR ;
Tschernyavsky, SJ ;
Woodruff, JM ;
Jungbluth, AA ;
Brennan, MF ;
Ladanyi, M .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2002, 4 (01) :44-52
[5]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[6]   MALIGNANT-MELANOMA OF SOFT PARTS - A REASSESSMENT OF CLEAR CELL-SARCOMA [J].
CHUNG, EB ;
ENZINGER, FM .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1983, 7 (05) :405-413
[7]  
Deenik W, 1999, CANCER, V86, P969, DOI 10.1002/(SICI)1097-0142(19990915)86:6<969::AID-CNCR11>3.0.CO
[8]  
2-Z
[9]  
ENZINGER FM, 1965, CANCER, V18, P1163, DOI 10.1002/1097-0142(196509)18:9<1163::AID-CNCR2820180916>3.0.CO
[10]  
2-0